ET-12 ANTI-VEGF THERAPY WITH KETOGENIC DIET AGAINST GLIOBLASTOMA IN MOUSE MODEL

NTRODUCTUION: Malignant glioma cells critically depend on glucose as the main energy source to survive and sustain their aggressive properties. The ketogenic diet (KD) has been proposed as a complementary therapy for treatment of malignant gliomas. VEGF inhibitor (bevacizumab) decreases blood supply...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasayama, Takashi, Maeyama, Masahiro, Tanaka, Kazuhiro, Fujita, Yuichi, Hashiguchi, Mitsuru, Irino, Yasuhiro, Kohmura, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213401/
http://dx.doi.org/10.1093/noajnl/vdz039.042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213401/
http://dx.doi.org/10.1093/noajnl/vdz039.042

Ejemplares similares